Anti-Human CD11a Fc Silent Antibody, Clone hu1124 (CAT#: CB-LX005-A) Datasheet

Product Type
Antibody
Description
Anti-Human CD11a-Fc silent antibody is derived from clone hu1124, which is a Human monoclonal antibody targeting the CD11a. And it is intended for the research of Neuroinflammation.
Research Area
Cell Biology, Immunology,
Antigen Distribution
CD11a is expressed on all leukocytes.
Disease
Neuroinflammation
Size
100 ug
Immunogen
Recombinant Human CD11a protein
Species
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1, Kappa
Clone Number
hu1124
Conjugation
Unconjugated
Source
Recombinant
Buffer
PBS, pH 7.4
Application
Block, ELISA, FuncS, FC, IHC
Application Notes
The use of diluent depends on the detection system used. It is recommended that users test reagents and determine their own optimal dilution.
Handling Advice
This product is for research use only. It is not intended for use in therapeutic or diagnostic procedures for humans or animals.
Storage Instructions
Product should be stored at -80°C. Repeated freeze and thaw cycles will cause loss of activity. Use product within 24 hours after thawing and keep on ice. Remainder amounts should be aliquoted and immediately re-freezed for future use. Aliquots should never be thawed more than once. Under recommended storage conditions, product is stable for at least one year.
Target
CD11a
Official Name
Integrin alpha-L
Full Name
Integrin alpha-L
Background
CD11a and CD18 are the Integrin alpha-L and beta-2 subunits that combine to form LFA-1, a glycoprotein and a member of the Integrin family. The Integrin alpha-L/beta-2 complex is a receptor for ICAM1, ICAM2, ICAM3, ICAM4 and F11R. LFA-1 participates in the immunological synapses between CD8+ T lymphocytes and antigen-presenting cells.
Alternative Names
ITGAL; integrin alpha L; LFA-1; LFA1A
Gene ID
Uniprot ID

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK